Atossa Genetics Operating Income 2012-2024 | ATOS

Atossa Genetics operating income from 2012 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Atossa Genetics Operating Income 2012-2024 | ATOS

Atossa Genetics operating income from 2012 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$211B
Intuitive Surgical (ISRG)$191.1B
Alcon (ALC)$45.7B
IQVIA Holdings (IQV)$39.8B
Edwards Lifesciences (EW)$39.1B
IDEXX Laboratories (IDXX)$35.5B
DexCom (DXCM)$27.3B
Waters (WAT)$22.8B
SONOVA HOLDING (SONVY)$22.1B
STERIS (STE)$21.6B
Hologic (HOLX)$18.3B
Sysmex ADR (SSMXY)$12.9B
Fresenius Medical Care AG KGaA (FMS)$12.5B
Globus Medical (GMED)$11B
Teleflex (TFX)$9.1B
Penumbra (PEN)$9.1B
Masimo (MASI)$8.7B
Glaukos (GKOS)$7.8B
PROCEPT BioRobotics (PRCT)$5.2B
Integer Holdings (ITGR)$4.6B
Inari Medical (NARI)$3B
TransMedics (TMDX)$2.9B
LivaNova (LIVN)$2.8B
Veracyte (VCYT)$2.8B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2B
Integra LifeSciences Holdings (IART)$1.9B
RxSight (RXST)$1.8B
Alphatec Holdings (ATEC)$1.3B